Urology · Oklahoma City, OK
NPI
1285015057
Since 2015
Specialty
Urology
Code 208800000X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
722 NW 28th St
Oklahoma City, OK, 73103
Phone (843) 324-4336
Groups this clinician bills Medicare through
Medicare paid, 2024
$532K
9,779 services
Medicare patients, 2024
510
Average age 74
Drug cost, 2024
$4.5M
2,880 prescriptions
Company payments, 2025
$2,529
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Caitlin Shepherd was code J9030 (bcg live intravesical instillation, 1 mg), 2,150 times for 19 patients. In total Caitlin Shepherd billed 9,779 services in 105 codes, and Medicare paid $532K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-06-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J9030 Bcg live intravesical instillation, 1 mg | Office | 2,150 | 19 | $2.28 | $4,912 |
| J1952 Leuprolide injectable, camcevi, 1 mg | Office | 1,554 | 24 | $45.23 | $70K |
| J0897 Injection, denosumab, 1 mg | Office | 1,440 | 15 | $20.51 | $30K |
| 99214 Office E&M - Established | Office | 545 | 286 | $92.80 | $51K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 516 | 284 | $11.84 | $6,111 |
| 81002 Clinical Chemistry | Office | 436 | 265 | $3.38 | $1,473 |
| 84153 Clinical Chemistry | Office | 202 | 113 | $18.02 | $3,640 |
| A4648 Tissue marker, implantable, any type, each | Office | 190 | 46 | $730.88 | $139K |
| 36415 Venipuncture Blood Collection | Office | 181 | 99 | $8.65 | $1,566 |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 156 | 39 | $50.45 | $7,870 |
| 84403 Clinical Chemistry | Office | 91 | 42 | $25.29 | $2,301 |
| 51798 Ultrasound - Nonspecific | Office | 68 | 57 | $7.60 | $517 |
| 99439 Chronic, Principal, and Transitional Care Management | Office | 67 | 33 | $38.98 | $2,612 |
| 99213 Office E&M - Established | Office | 66 | 56 | $66.96 | $4,419 |
| 80053 Clinical Chemistry | Office | 56 | 22 | $10.35 | $580 |
By year: 2022 $175K for 3,354 services; 2023 $344K for 8,121 services; 2024 $532K for 9,779 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81002 Clinical Chemistry | 436 | 265 | $3.38 | $1,473 |
| 84153 Clinical Chemistry | 202 | 113 | $18.02 | $3,640 |
| 36415 Venipuncture Blood Collection | 181 | 99 | $8.65 | $1,566 |
| 84403 Clinical Chemistry | 91 | 42 | $25.29 | $2,301 |
| 80053 Clinical Chemistry | 56 | 22 | $10.35 | $580 |
| 87086 Bacterial Culture | 17 | 17 | $7.91 | $134 |
| 87088 Bacterial Culture | 13 | 13 | $7.93 | $103 |
| 82565 Clinical Chemistry | 13 | 12 | $5.02 | $65.26 |
| 84520 Clinical Chemistry | 12 | 11 | $3.87 | $46.44 |
| 87077 Bacterial Culture | 11 | 11 | $7.34 | $80.75 |
Medicare prescription drug claims, 2024
In 2024, the drug Caitlin Shepherd prescribed most often to Medicare patients was Tamsulosin Hcl, with 593 prescriptions and refills. In total Caitlin Shepherd wrote 2,880 Medicare prescriptions that cost $4.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 593 | 1,465 | 177 | $8,862 |
| Abiraterone Acetate Generic | 457 | 473 | 59 | $1.3M |
| Prednisone Generic | 389 | 449 | 56 | $1,432 |
| Finasteride Generic | 251 | 724 | 76 | $2,614 |
| Orgovyx Relugolix | 197 | 197 | 25 | $519K |
| Gemtesa Vibegron | 90 | 130 | 22 | $52K |
| Nitrofurantoin Nitrofurantoin Macrocrystal | 71 | 161 | 27 | $1,940 |
| Myrbetriq Mirabegron | 65 | 99 | 23 | $45K |
| Erleada Apalutamide | 64 | 64 | 11 | $906K |
| Oxybutynin Chloride Er Oxybutynin Chloride | 63 | 178 | 25 | $1,650 |
| Nubeqa Darolutamide | 61 | 61 | Under 11 | $730K |
| Xtandi Enzalutamide | 55 | 55 | Under 11 | $680K |
| Ciprofloxacin Hcl Generic | 44 | 50 | 34 | $246 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 44 | 52 | 28 | $107 |
| Oxycodone Hcl Generic | 43 | 43 | 37 | $149 |
Brand drugs: 630 claims; generic drugs: 2,250 claims; opioid claims: 51.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Caitlin Shepherd $2,529 ($2,529 in general payments such as food, travel and fees) from 29 companies. The largest payer was Teleflex LLC with $346.
| Company | Payments | Amount |
|---|---|---|
| Teleflex LLC TFX | 3 | $346 |
| Ferring Pharmaceuticals Inc. | 9 | $320 |
| Janssen Biotech, Inc. JNJ | 3 | $191 |
| Immunitybio, Inc. IBRX | 6 | $152 |
| Histosonics, Inc. | 1 | $135 |
| Boston Scientific Corporation BSX | 2 | $133 |
| Calyxo, Inc. | 1 | $131 |
| Janssen Scientific Affairs, LLC JNJ | 1 | $124 |
| Sumitomo Pharma America, Inc. 4506.T | 7 | $117 |
| Endo USA, Inc. | 4 | $98.69 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.